FindTrial
Sign In

Selegiline in Treatment of Cocaine Dependence - 2

Selegiline in Treatment of Cocaine Dependence

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000188
Enrollment
50
Registered
1999-09-21
Start date
1994-09-30
Completion date
1995-10-31
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

Cocaine Dependence, Selegiline

Brief summary

The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.

Interventions

DRUGSelegiline

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Retention—
Cocaine use—
Cocaine craving—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026